Wegovy (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity, to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight and that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off
Notice how there is no sharp in between E - F and B -C, The ascending series of these notes is a chromatic scale
Eleven percent of covered workers are in a plan where the worker contributes more than half of the premium for family coverage [Figure 6.10]
Although the medications are often casually referred to as GLP-1s, its just a common shorthand that describes how they work similarly to the bodys own natural GLP-1s
Studies have shown that Ozempic and other GLP-1s work best when theyre treated as long-term medications and taken at a full dose
This brings about a reduction in blood glucose levels, in addition to reducing glycosylated hemoglobin levels which have an impact on body weight